Alector ALEC Stock
Alector Price Chart
Alector ALEC Financial and Trading Overview
| Alector stock price | 1.16 USD |
| Previous Close | 7.71 USD |
| Open | 7.72 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1300 |
| Day's Range | 7.54 - 7.81 USD |
| 52 Week Range | 5.76 - 13.5 USD |
| Volume | 346.62K USD |
| Avg. Volume | 525.15K USD |
| Market Cap | 635.14M USD |
| Beta (5Y Monthly) | 0.778085 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.23 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11 USD |
ALEC Valuation Measures
| Enterprise Value | 7.99M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.14876 |
| PEG Ratio (5 yr expected) | 0.23 |
| Price/Sales (ttm) | 5.0531516 |
| Price/Book (mrq) | 3.4699452 |
| Enterprise Value/Revenue | 0.064 |
| Enterprise Value/EBITDA | -0.058 |
Trading Information
Alector Stock Price History
| Beta (5Y Monthly) | 0.778085 |
| 52-Week Change | -10.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 13.5 USD |
| 52 Week Low | 5.76 USD |
| 50-Day Moving Average | 7.08 USD |
| 200-Day Moving Average | 8.21 USD |
ALEC Share Statistics
| Avg. Volume (3 month) | 525.15K USD |
| Avg. Daily Volume (10-Days) | 450.24K USD |
| Shares Outstanding | 83.35M |
| Float | 62.01M |
| Short Ratio | 13.11 |
| % Held by Insiders | 11.03% |
| % Held by Institutions | 81.57% |
| Shares Short | 6.33M |
| Short % of Float | 10.08% |
| Short % of Shares Outstanding | 7.58% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -107.046% |
| Operating Margin (ttm) | -114.42% |
| Gross Margin | -66.48% |
| EBITDA Margin | -110.063% |
Management Effectiveness
| Return on Assets (ttm) | -10.55% |
| Return on Equity (ttm) | -59.72% |
Income Statement
| Revenue (ttm) | 125.69M USD |
| Revenue Per Share (ttm) | 1.52 USD |
| Quarterly Revenue Growth (yoy) | -32.39% |
| Gross Profit (ttm) | -76801000 USD |
| EBITDA | -138340992 USD |
| Net Income Avi to Common (ttm) | -134550000 USD |
| Diluted EPS (ttm) | -1.62 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 669.33M USD |
| Total Cash Per Share (mrq) | 8.03 USD |
| Total Debt (mrq) | 42.18M USD |
| Total Debt/Equity (mrq) | 23.05 USD |
| Current Ratio (mrq) | 6.908 |
| Book Value Per Share (mrq) | 2.196 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -203968000 USD |
| Levered Free Cash Flow (ttm) | -79015248 USD |
Profile of Alector
| Country | United States |
| State | CA |
| City | South San Francisco |
| Address | 131 Oyster Point Boulevard |
| ZIP | 94080 |
| Phone | 415 231 5660 |
| Website | https://www.alector.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 273 |
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, an immune activity in the brain with genetic links to multiple neurodegenerative disorders, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's disease. Its pipeline products include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001, AL002, and AL101 to treat neurodegenerative diseases. Alector, Inc. was founded in 2013 and is headquartered in South San Francisco, California.
Q&A For Alector Stock
What is a current ALEC stock price?
Alector ALEC stock price today per share is 1.16 USD.
How to purchase Alector stock?
You can buy ALEC shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Alector?
The stock symbol or ticker of Alector is ALEC.
Which industry does the Alector company belong to?
The Alector industry is Biotechnology.
How many shares does Alector have in circulation?
The max supply of Alector shares is 99.09M.
What is Alector Price to Earnings Ratio (PE Ratio)?
Alector PE Ratio is now.
What was Alector earnings per share over the trailing 12 months (TTM)?
Alector EPS is -1.23 USD over the trailing 12 months.
Which sector does the Alector company belong to?
The Alector sector is Healthcare.
Alector ALEC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17449.89 USD — |
+0.87
|
6.97B USD — | 17149.36 USD — | 17506.58 USD — | — - | 6.97B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4486.38 USD — |
-0.37
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8541.08 USD — |
+0.91
|
— — | 8392.44 USD — | 8567.09 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4132.89 USD — |
-2.63
|
— — | 4122.19 USD — | 4247.3 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 929.13 USD — |
-1.85
|
— — | 925.14 USD — | 947.12 USD — | — - | — — |
- {{ link.label }} {{link}}